Hepatocellular carcinoma (HCC), or liver cancer, is the third leading cause of cancer deaths worldwide \[[@b114-ehp-118-818]\], with roughly 550,000--600,000 new HCC cases globally each year ([@b29-ehp-118-818]). Aflatoxin exposure in food is a significant risk factor for HCC ([@b115-ehp-118-818]). Aflatoxins are primarily produced by the food-borne fungi *Aspergillus flavus* and *Aspergillus parasiticus*, which colonize a variety of food commodities, including maize, oilseeds, spices, groundnuts, and tree nuts in tropical and subtropical regions of the world. Additionally, when animals that are intended for dairy production consume aflatoxin-contaminated feed, a metabolite, aflatoxin M~1~, is excreted in the milk ([@b95-ehp-118-818]).

Aflatoxins are a group of approximately 20 related fungal metabolites. The four major aflatoxins are known as B~1~, B~2~, G~1~, and G~2~. Aflatoxins B~2~ and G~2~ are the dihydro-derivatives of the parent compounds B~1~ and G~1~ ([@b84-ehp-118-818]). Aflatoxin B~1~ (AFB1) is the most potent (in some species) naturally occurring chemical liver carcinogen known. Naturally occurring mixes of aflatoxins have been classified as a Group 1 human carcinogen by the International Agency for Research on Cancer (IARC) and has demonstrated carcinogenicity in many animal species, including some rodents, nonhuman primates, and fish \[[@b45-ehp-118-818])\]. Specific P450 enzymes in the liver metabolize aflatoxin into a reactive oxygen species (aflatoxin-8,9-epoxide), which may then bind to proteins and cause acute toxicity (aflatoxicosis) or to DNA to cause lesions that over time increase the risk of HCC ([@b35-ehp-118-818]).

HCC as a result of chronic aflatoxin exposure has been well documented, presenting most often in persons with chronic hepatitis B virus (HBV) infection ([@b115-ehp-118-818]). The risk of liver cancer in individuals exposed to chronic HBV infection and aflatoxin is up to 30 times greater than the risk in individuals exposed to aflatoxin only ([@b35-ehp-118-818]). These two HCC risk factors---aflatoxin and HBV---are prevalent in poor nations worldwide. Within these nations, there is often a significant urban--rural difference in aflatoxin exposure and HBV prevalence, with both these risk factors typically affecting rural populations more strongly ([@b85-ehp-118-818]).

Aflatoxin also appears to have a synergistic effect on hepatitis C virus (HCV)-induced liver cancer ([@b54-ehp-118-818]; [@b57-ehp-118-818]; [@b117-ehp-118-818]), although the quantitative relationship is not as well established as that for aflatoxin and HBV in inducing HCC. Other important causative factors in the development of HCC, in addition to HBV or HCV infection and aflatoxin exposure, are the genetic characteristics of the virus, alcohol consumption, and the age and sex of the infected person ([@b54-ehp-118-818]).

The IPCS/WHO undertook an aflatoxin--HCC risk assessment in 1998 to estimate the impact on population cancer incidence by moving from a hypothetical total aflatoxin standard of 20 ng/g to 10 ng/g ([@b42-ehp-118-818]; [@b45-ehp-118-818]). Assuming that all food containing higher levels of aflatoxin than the standard was discarded and that enough maize and nuts remained to preserve consumption patterns, IPCS/WHO determined that HCC incidence would decrease by about 300 cases per year per billion people, if the stricter aflatoxin standard were followed in nations with HBV prevalence of 25%. However, in nations where HBV prevalence was 1%, the stricter aflatoxin standard would save only two HCC cases per year per billion people. This assessment associated HCC risk with particular doses of aflatoxin; however, these doses do not correspond with actual exposure in different parts of the world, and the two hypothetical values for HBV prevalence, 1% and 25%, were not intended to represent actual HBV prevalence worldwide.

Currently, \> 55 billion people worldwide suffer from uncontrolled exposure to aflatoxin ([@b95-ehp-118-818]). What remains unknown is how many cases of liver cancer can be attributed to this aflatoxin exposure worldwide. Indeed, the Aflatoxin Workgroup ([@b95-ehp-118-818]), convened by the Centers for Disease Control and Prevention and WHO, identified four issues that warrant immediate attention: quantifying human health impacts and burden of disease due to aflatoxin exposure, compiling an inventory of ongoing intervention strategies, evaluating their efficacy, and disseminating the results.

Addressing this first issue is the aim of our study. We compiled available information on aflatoxin exposure and HBV prevalence from multiple nations in a quantitative cancer risk assessment, to estimate the number of HCC cases attributable to aflatoxin worldwide per year. [@b91-ehp-118-818] estimated population risk for aflatoxin-induced HCC in select African nations; we expand this to include the rest of the world. We briefly describe interventions that can either reduce aflatoxin directly in food or reduce adverse health effects caused by aflatoxin.

Materials and Methods
=====================

To perform a quantitative cancer risk assessment for aflatoxin-related HCC, we analyzed extensive data sets by nation or world region: food consumption patterns (of maize and peanuts), aflatoxin levels in maize and peanuts, HBV prevalence, and population size. Risk assessment is the process of estimating the magnitude and the probability of a harmful effect to individuals or populations from certain agents or activities. Four steps are involved in estimation of the risk: hazard identification, dose--response analysis, exposure assessment, and risk characterization ([@b76-ehp-118-818]).

Hazard identification
---------------------

Hazard identification is the process of determining whether exposure to an agent can increase the incidence of a particular health condition. Aflatoxin exposure is associated with an increase in incidence of HCC in humans and sensitive animal species ([@b35-ehp-118-818]); in fact, IARC has classified AFB1 naturally occurring mixes of aflatoxins as a Group 1 carcinogen ([@b44-ehp-118-818]).

Dose--response analysis
-----------------------

This second risk assessment step involves characterizing the relationship between the dose of an agent---in this case, aflatoxin---and incidence of HCC. Because of the synergistic impact of aflatoxin and HBV in inducing HCC, the assessment must be done separately for populations with and without chronic HBV infection. Although chronic HCV infection may also have synergistic effects with aflatoxin in inducing HCC, we did not include this effect in the analyses for three reasons: *a*) there is much less overlap worldwide between aflatoxin and HCV exposures in general; *b*) chronic HCV infection usually occurs later in life, whereas chronic HBV infection occurs much earlier, thus the time of overlapped exposure is less significant for aflatoxin and HCV (Groopman J, personal communication); and *c*) much less is known about the quantitative relationship of aflatoxin and HCV in inducing HCC.

For cancer risk assessment, it is traditionally assumed that there is no threshold of exposure to a carcinogen below which there is no observable adverse effect ([@b77-ehp-118-818]). Cancer potency factors are estimated from the slope of the dose--response relationship, which is assumed to be linear, between doses of the carcinogen and cancer incidence in a population. The IPSC/WHO aflatoxin risk assessment selected two different cancer potency factors for aflatoxin: 0.01 cases/100,000/year/nanogram/kilogram body weight per day aflatoxin exposure for individuals without chronic HBV infection, and 0.30 corresponding cases for individuals with chronic HBV infection. This was based on one cohort study that estimated cancer potency in individuals positive for the HBV surface antigen (HBsAg; a biomarker of chronic HBV infection) and in HBsAg-negative individuals ([@b122-ehp-118-818]), as well as other human studies that assessed cancer potency among either HBsAg-positive or HBsAg-negative individuals. We used these same potency factors for this risk assessment. Because only one of the studies ([@b122-ehp-118-818]) specifically assessed cancer potency in both cohorts, considerable uncertainty may be associated with these potency factors. However, several epidemiological studies confirm that aflatoxin's cancer potency is about 30 times greater among HBV-positive than among HBV-negative individuals ([@b56-ehp-118-818], [@b79-ehp-118-818]; [@b86-ehp-118-818]).

Exposure assessment
-------------------

Exposure assessment involves estimating the intensity, frequency, and duration of human exposures to a toxic agent. Specifically, we sought to determine how individuals' exposure to aflatoxin increases their risk of HCC. Aflatoxin exposure is a function not only of aflatoxin concentrations in maize and nuts but also of how much of these foodstuffs individuals consume in different parts of the world.

Aflatoxin exposure assessment has evolved significantly over the past two decades, largely due to the characterization of biomarkers for both aflatoxin exposure and effect ([@b34-ehp-118-818], [@b35-ehp-118-818]). Before these biomarkers, the primary way to estimate aflatoxin exposure was to observe how much maize and nuts people consumed on average and to measure or assume aflatoxin levels in these foods. By measuring biomarkers such as aflatoxin--albumin adducts in serum or aflatoxin-N7-guanine in urine, it is possible to improve estimations of aflatoxin exposure and how much has been biotransformed to increase cancer risk ([@b35-ehp-118-818]).

Because aflatoxin biomarker data worldwide are limited, we collected data on estimated HBV prevalence in these countries and on maize and nut consumption patterns in different world regions and estimated average aflatoxin exposure or contamination levels in the maize and nuts in different world regions. Where aflatoxin exposure data were not already estimated, we used food consumption patterns and aflatoxin contamination levels to estimate exposure. The studies estimating HBV prevalence were based on HBsAg detection among males and among females in both urban and rural settings across all age groups. Data on maize and peanut consumption in different world regions are adapted from the WHO Global Environment Monitoring System (GEMS)/Food Consumption Cluster Diets database ([@b112-ehp-118-818]). We estimated aflatoxin exposure data in different nations from multiple sources through literature searches.

Risk characterization
---------------------

This final step of risk assessment integrates dose--response and exposure data to describe the overall nature and magnitude of risk. For our study, this final step consisted of quantifying, across the globe, the burden of aflatoxin-related liver cancer. For each nation, we estimated total number of individuals with or without chronic HBV by multiplying prevalence by population size. To estimate aflatoxin-induced HCC rates within these two populations (with and without chronic HBV infection), we multiplied the corresponding cancer potency factor by aflatoxin exposure estimates. Then we multiplied these values by each nation's HBV-positive and HBV-negative population sizes to derive total number of aflatoxin-induced HCC cases in each nation. We summed across all world regions to arrive at an estimate for global burden of aflatoxin-induced HCC.

Results
=======

[Table 1](#t1-ehp-118-818){ref-type="table"} lists the prevalence of chronic HBV infection by world region, as measured by HBsAg in different parts of the world. Although these different estimates involve uncertainty and variability, all data are from literature published in or after 2000, to ensure that the HBV prevalence estimates are as current and as relevant as possible. Countries are grouped by WHO designated regions ([@b111-ehp-118-818]): Africa, North America and Latin America, Eastern Mediterranean, Southeast Asia, Western Pacific, and Europe. Some regions were divided into subgroups because of significantly varied aflatoxin exposure and HBV prevalence within the region.

[Table 2](#t2-ehp-118-818){ref-type="table"} provides calculations of maize and peanut consumption in select countries of the world. The GEMS/Food Consumption Cluster Diets database divides countries of the world into 13 groups based on diets. For each group cluster, the GEMS food consumption database has estimated the amount of cereals, nuts, and oilseeds consumed. We thus estimated average maize and nut consumption by individual country. There are limitations to these data because of the clustering into 13 groups (with potentially wide ranges among nations within a group), as well as variability in data quality regarding diet and aflatoxin exposure estimates.

We estimated (based on [Tables 1](#t1-ehp-118-818){ref-type="table"} and [2](#t2-ehp-118-818){ref-type="table"}) or found in the literature the average aflatoxin exposure in different world regions and then calculated the estimated incidence of aflatoxin-induced HCC, with and without the synergistic impact with HBV, in the corresponding populations of each nation and world region ([Table 3](#t3-ehp-118-818){ref-type="table"}). Within each WHO-designated region, we found aflatoxin exposures in the most populous nations. The "in general" rows in [Table 3](#t3-ehp-118-818){ref-type="table"} represent a small proportion of each region: nations in which aflatoxin data were not available, or very small nations. For these, we assumed a range for aflatoxin exposure that incorporated the ranges of the nations within the region for which we found aflatoxin data.

These data provide the necessary information to calculate the total estimated cases of aflatoxin-induced HCC cases annually, worldwide. [Table 4](#t4-ehp-118-818){ref-type="table"} lists populations for each relevant nation and world region. Accounting for chronic HBV infection prevalence as shown in [Table 1](#t1-ehp-118-818){ref-type="table"}, and the risk estimates for HBV-positive versus HBV-negative individuals in [Table 3](#t3-ehp-118-818){ref-type="table"}, the numbers of cases of aflatoxin-induced HCC can be estimated in each world region. These are then summed to produce a global estimate of the number of annual aflatoxin-induced HCC cases. Our estimate is that anywhere from 25,200 to 155,000 annual HCC cases worldwide may be attributable to aflatoxin exposure.

[Figure 1](#f1-ehp-118-818){ref-type="fig"} illustrates the distribution of HCC cases attributable to aflatoxin globally. The categories denote WHO world regions. Sub-Saharan Africa is the most important region for HCC cases attributable to aflatoxin; Southeast Asia and China (in the Western Pacific region) are also key regions where aflatoxin-related HCC is an important risk. Relatively fewer cases occur in the Americas, Eastern Mediterranean, and Europe. Although Australia and New Zealand are grouped with the Western Pacific region, these nations also have low aflatoxin-induced HCC incidence. It is notable that in Mexico, where HBV prevalence is relatively low but aflatoxin contamination in food is relatively high, aflatoxin appears to be a significant risk factor for HCC among those without HBV (an estimated 152--924 HCC cases per year per 100,000 people).

Discussion
==========

Aflatoxin contamination in food is a serious global health problem, particularly in developing countries. Although it has been known for several decades that aflatoxin causes liver cancer in humans, the exact burden of aflatoxin-related HCC worldwide was unknown. This study represents a first step in attempting to estimate that burden. We find that at its lower estimate, aflatoxin plays a role in about 4.6% of total annual HCC cases; at its upper estimate, aflatoxin may play a role roughly 28.2% of all HCC cases worldwide. This large range stems from the considerable uncertainty and variability in data on cancer potency factors, HBV prevalence, aflatoxin exposure, and other risk factors in different world regions. The most heavily afflicted parts of the world are sub-Saharan Africa, Southeast Asia, and China.

As indicated in [Table 3](#t3-ehp-118-818){ref-type="table"}, populations in developing countries in tropical and subtropical areas are nearly ubiquitously exposed to moderate to high levels of aflatoxin. Aflatoxin is a controllable risk factor in food, yet the parts of the world in which the risk is particularly high have limited resources to implement most aflatoxin control strategies. Much agricultural land in Africa and Asia lies in climatic regions favorable for *A. flavus* and *A. parasiticus* proliferation. Suboptimal field practices and poor drying/storage conditions make crops vulnerable to fungal infection and aflatoxin accumulation. Maize and groundnuts, the two crops most conducive to *Aspergillus* infection, are staples in many African and Asian diets. Because the very poor in these regions cannot afford much food variety, these staples make up a significant portion of their diets, increasing aflatoxin exposure.

Even within the same nation, aflatoxin-induced HCC risk can vary significantly among different populations, hence the large national ranges for risk shown in [Table 4](#t4-ehp-118-818){ref-type="table"}. Rural populations generally have higher levels of aflatoxin exposure than do urban dwellers in developing countries ([@b116-ehp-118-818]), because urban populations typically consume more diversified diets than do rural dwellers and may have food that is better controlled for contaminants. In addition, there is a strong seasonal variation in aflatoxin exposure that correlates with food availability ([@b32-ehp-118-818]; [@b97-ehp-118-818]). Moreover, HBV prevalence is generally higher in rural areas than in urban ones, and higher among males than among females in most places ([@b85-ehp-118-818]). We present our collected data of HBsAg seroprevalence as a range for countries or populations ([Table 1](#t1-ehp-118-818){ref-type="table"}), to account for these variations.

Although many nations that suffer from both high aflatoxin exposures and high HBV prevalence have nominally established maximum allowable aflatoxin standards in food, there is little if any enforcement of these standards in many rural areas. Indeed, the food in subsistence farming and local food markets is rarely formally inspected. Strict aflatoxin standards can even lead to large economic losses for poor food-exporting nations when trading with other nations ([@b120-ehp-118-818]). Subsistence farmers and local food traders sometimes have the luxury of discarding obviously moldy maize and groundnuts. But in drought seasons, oftentimes people have no choice but to eat moldy food or starve ([@b118-ehp-118-818]).

Multiple public health interventions exist to control the burden of aflatoxin in the body and to prevent HCC. These interventions, described in greater detail in [@b121-ehp-118-818], can be grouped into three categories: agricultural, dietary, and clinical. Agricultural interventions can be applied either in the field (preharvest) or in storage and transportation (postharvest) to reduce aflatoxin levels in key crops. They can thus be considered primary interventions. Dietary and clinical interventions can be considered secondary interventions. They cannot reduce actual aflatoxin levels in food, but they can reduce aflatoxin-related illness, either by reducing aflatoxin's bioavailability in the body or by ameliorating aflatoxin-induced damage. Because aflatoxin-mediated mutations may precede HCC by several years, the effects of reducing aflatoxin exposure on HCC incidence may take time to become apparent ([@b96-ehp-118-818]).

One highly effective clinical intervention to reduce aflatoxin-related HCC is vaccination against HBV. Vaccinating children against HBV has, over the past 30 years, significantly decreased HBV infection in several regions, including Europe ([@b16-ehp-118-818]; [@b119-ehp-118-818]), Taiwan ([@b20-ehp-118-818]), and Thailand ([@b49-ehp-118-818]). This vaccine will, over time, lessen the global carcinogenic impact of aflatoxin, because removing the synergistic impact between HBV and aflatoxin exposure would significantly reduce HCC risk. However, there are currently roughly 360 million chronic HBV carriers worldwide, and HBV vaccination is still not incorporated into many national immunization programs ([@b116-ehp-118-818]). Thus, adopting measures to reduce dietary exposure to aflatoxins is crucial for public health.

Our study highlights the significant role of aflatoxin in contributing to global liver cancer burden. Most cases occur in sub-Saharan Africa, Southeast Asia, and China, where populations suffer from both high HBV prevalence and largely uncontrolled exposure to aflatoxin in the food. Not all risk factors for HCC, including synergistic roles between aflatoxin and other carcinogens, are clearly understood; hence, these estimates for number of global aflatoxin-induced HCC cases have a large range. Although it is impossible to completely eliminate aflatoxin in food worldwide, it is possible to significantly reduce levels and dramatically reduce liver cancer incidence worldwide. The challenge remains to deliver these interventions to places of the world where they are most needed.
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###### 

Estimates of HBV prevalence in select countries based on HBsAg seroprevalence.

  WHO region/country                References                                                                      Chronic HBV prevalence (%)
  --------------------------------- ------------------------------------------------------------------------------- ----------------------------
  Africa                                                                                                            
  Democratic Republic of Congo      [@b13-ehp-118-818]; [@b68-ehp-118-818]                                          6--10
  Ethiopia                          [@b1-ehp-118-818]; [@b92-ehp-118-818]                                           6--7
  The Gambia                        [@b55-ehp-118-818]; [@b105-ehp-118-818]                                         15--20
  Kenya                             [@b53-ehp-118-818]; [@b104-ehp-118-818]                                         11--15
  Mozambique                        [@b22-ehp-118-818]                                                              4.5--10.6
  Nigeria                           [@b28-ehp-118-818]                                                              13.2
  South Africa                      [@b23-ehp-118-818]; [@b53-ehp-118-818]                                          3.3--10.4
  Tanzania                          [@b41-ehp-118-818]; [@b66-ehp-118-818]; [@b71-ehp-118-818]                      5--9
  Zimbabwe                          [@b53-ehp-118-818]; [@b103-ehp-118-818]                                         10--15
  Others                            [@b53-ehp-118-818]; [@b66-ehp-118-818]; [@b100-ehp-118-818]                     9--20
                                                                                                                    
  North America and Latin America                                                                                   
  Canada                            [@b72-ehp-118-818]; [@b124-ehp-118-818]                                         1--2
  United States                     [@b18-ehp-118-818]; [@b21-ehp-118-818]; [@b111-ehp-118-818]                     0.3--2
  Argentina                         [@b82-ehp-118-818]; [@b101-ehp-118-818]                                         0.8--1.1
  Brazil                            [@b82-ehp-118-818]; [@b101-ehp-118-818]                                         2.1--3.4
  Mexico                            [@b88-ehp-118-818]                                                              \< 0.3
  Others                            [@b82-ehp-118-818]; [@b101-ehp-118-818]                                         0.5--3
                                                                                                                    
  Eastern Mediterranean                                                                                             
  Egypt                             [@b46-ehp-118-818]; [@b60-ehp-118-818]; [@b123-ehp-118-818]                     2.2--10.1
  Iran                              [@b50-ehp-118-818], [@b51-ehp-118-818]                                          0.41--0.56
  Pakistan                          [@b17-ehp-118-818]; [@b52-ehp-118-818]                                          3.3
  Sudan                             [@b26-ehp-118-818]                                                              6--26
  Others                            [@b2-ehp-118-818]; [@b12-ehp-118-818]; [@b7-ehp-118-818]; [@b111-ehp-118-818]   0.65--10
                                                                                                                    
  Southeast Asia                                                                                                    
  India                             [@b15-ehp-118-818]; [@b98-ehp-118-818]                                          2.4-- 4.7
  Indonesia                         [@b43-ehp-118-818]; [@b69-ehp-118-818]; [@b106-ehp-118-818]                     2.5--5
  Thailand                          [@b99-ehp-118-818]                                                              4.6--8
  Others                            [@b3-ehp-118-818]; [@b6-ehp-118-818]; [@b47-ehp-118-818]; [@b111-ehp-118-818]   2--7
                                                                                                                    
  Western Pacific                                                                                                   
  Australia                         [@b113-ehp-118-818]                                                             \< 1
  China                             [@b69-ehp-118-818]; [@b113-ehp-118-818]                                         8--10
  Malaysia                          [@b69-ehp-118-818]; [@b113-ehp-118-818]                                         5
  Philippines                       [@b25-ehp-118-818]; [@b59-ehp-118-818]; [@b113-ehp-118-818]                     5--16
  Korea                             [@b94-ehp-118-818]; [@b113-ehp-118-818]                                         4--5
  Others                            [@b36-ehp-118-818]; [@b69-ehp-118-818]; [@b74-ehp-118-818]                      1--10
                                                                                                                    
  Europe                                                                                                            
  Eastern Europe                    [@b63-ehp-118-818]; [@b87-ehp-118-818]                                          2--7
  Southern Europe                   [@b24-ehp-118-818]; [@b33-ehp-118-818]; [@b111-ehp-118-818]                     2--7
  Western Europe                    [@b39-ehp-118-818]; [@b111-ehp-118-818]; [@b48-ehp-118-818]                     0.5--1

CDC, Centers for Disease Control and Prevention.

###### 

Maize and peanut consumption in select countries.

  WHO region/country                Maize[a](#tfn3-ehp-118-818){ref-type="table-fn"} (g/person/day)   Peanut[b](#tfn4-ehp-118-818){ref-type="table-fn"} (g/person/day)
  --------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------------
  Africa                                                                                              
  Democratic Republic of Congo      57                                                                52
  Ethiopia                          83                                                                13
  The Gambia                        57                                                                52
  Kenya                             248                                                               11
  Mozambique                        248                                                               11
  Nigeria                           57                                                                52
  South Africa                      248                                                               11
  Tanzania                          248                                                               11
  Zimbabwe                          248                                                               11
                                                                                                      
  North America and Latin America                                                                     
  Canada                            86                                                                17
  United States                     86                                                                17
  Argentina                         86                                                                17
  Brazil                            63                                                                2
  Mexico                            300                                                               5
                                                                                                      
  Eastern Mediterranean                                                                               
  Egypt                             136                                                               5
  Iran                              32                                                                2
  Pakistan                          35                                                                18
  Sudan                             57                                                                52
                                                                                                      
  Southeast Asia                                                                                      
  India                             35                                                                18
  Indonesia                         35                                                                18
  Thailand                          35                                                                18
                                                                                                      
  Western Pacific                                                                                     
  Australia                         86                                                                17
  China                             35                                                                18
  Malaysia                          35                                                                18
  Philippines                       59                                                                2
  Republic of Korea                 59                                                                2
                                                                                                      
  Europe                                                                                              
  Eastern Europe                    32                                                                2--10
  Southern Europe                   148                                                               7
  Western Europe                    33                                                                10

Data are adapted from GEMS/Food Consumption Cluster Diets database ([@b112-ehp-118-818]).

Including maize, flour and germ.

Including groundnuts in shell and shelled.

###### 

Estimated HCC incidence attributable to aflatoxin, by WHO region.

  WHO region/country                                      Reference                                                                                                                     Aflatoxin exposure (ng/kg body weight/day[a](#tfn6-ehp-118-818){ref-type="table-fn"})   Estimated annual HCC (per 100,000)   
  ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ------------------------------------ ------------
  Africa                                                                                                                                                                                                                                                                                                             
  Democratic Republic of Congo                            [@b65-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                                                 0.07--27                                                                                0.0007--0.27                         0.02--8.10
  Ethiopia                                                [@b9-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                                                  1.4--36                                                                                 0.01--0.36                           0.42--10.8
  The Gambia                                              [@b40-ehp-118-818]; [@b91-ehp-118-818]                                                                                        4--115                                                                                  0.04--1.15                           1.20--34.5
  Kenya                                                   [@b40-ehp-118-818]; [@b91-ehp-118-818]                                                                                        3.5--133                                                                                0.04--1.33                           1.05--39.9
  Mozambique                                              [@b40-ehp-118-818]                                                                                                            39--180                                                                                 0.39--1.80                           11.7--54.0
  Nigeria                                                 [@b10-ehp-118-818]; [@b11-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                             139--227                                                                                1.39--2.27                           41.7--68.1
  South Africa                                            [@b40-ehp-118-818]; [@b90-ehp-118-818]                                                                                        0--17                                                                                   0--0.17                              0--5.10
  Tanzania                                                [@b65-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                                                 0.02--50                                                                                0.0002--0.50                         0.06--15.0
  Zimbabwe                                                [@b45-ehp-118-818]                                                                                                            17.5--42.5                                                                              0.18--0.43                           5.25--12.8
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}   [@b40-ehp-118-818]; [@b91-ehp-118-818]                                                                                        10--180                                                                                 0.10--1.80                           3.0--54.0
                                                                                                                                                                                                                                                                                                                     
  North America                                                                                                                                                                                                                                                                                                      
  Canada                                                  [@b58-ehp-118-818]                                                                                                            0.2--0.4[d](#tfn9-ehp-118-818){ref-type="table-fn"}                                     0.002--0.004                         0.06--0.12
  United States                                           [@b45-ehp-118-818]                                                                                                            0.26                                                                                    0.003                                0.08
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 0.26--1                                                                                 0.003--0.01                          0.08--0.3
                                                                                                                                                                                                                                                                                                                     
  Latin America                                                                                                                                                                                                                                                                                                      
  Argentina                                               [@b27-ehp-118-818]; [@b93-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                             0--4                                                                                    0--0.04                              0--1.20
  Brazil                                                  [@b44-ehp-118-818]; [@b70-ehp-118-818]; [@b80-ehp-118-818]; [@b107-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}    0.23--50                                                                                0.002--0.50                          0.07--15.0
  Mexico                                                  [@b30-ehp-118-818]; [@b37-ehp-118-818]; [@b102-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                        14--85                                                                                  0.14--0.85                           4.20--25.5
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 20--50                                                                                  0.20--0.50                           6.0--15.0
                                                                                                                                                                                                                                                                                                                     
  Eastern Mediterranean                                                                                                                                                                                                                                                                                              
  Egypt                                                   [@b8-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                                                  7--57                                                                                   0.07--0.57                           2.1--17.1
  Iran                                                    [@b38-ehp-118-818]; [@b67-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                             5--8.5                                                                                  0.05--0.09                           1.50--2.55
  Pakistan                                                [@b73-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                                                 7--50                                                                                   0.07--0.50                           2.10--15.0
  Sudan                                                   [@b81-ehp-118-818]                                                                                                            19--186                                                                                 0.19--1.86                           5.70--55.8
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 10--80                                                                                  0.10--0.80                           3.00--24.0
                                                                                                                                                                                                                                                                                                                     
  Southeast Asia                                                                                                                                                                                                                                                                                                     
  India                                                   [@b108-ehp-118-818]                                                                                                           4--100                                                                                  0.04--1.00                           1.20--30.0
  Indonesia                                               [@b5-ehp-118-818]; [@b44-ehp-118-818]; [@b78-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                          9--122                                                                                  0.09--1.22                           2.7--36.6
  Thailand                                                [@b40-ehp-118-818]; [@b62-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                             53--73                                                                                  0.53--0.73                           15.9--21.9
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 30--100                                                                                 0.30--1.00                           9.00--30.0
                                                                                                                                                                                                                                                                                                                     
  Western Pacific                                                                                                                                                                                                                                                                                                    
  Australia                                               [@b75-ehp-118-818]; [@b84-ehp-118-818]                                                                                        0.15--0.18                                                                              \~0.002                              \~0.05
  China                                                   [@b61-ehp-118-818]; [@b86-ehp-118-818]; [@b110-ehp-118-818]; [@b109-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}   17--37                                                                                  0.17--0.37                           5.10--11.1
  Malaysia                                                [@b4-ehp-118-818]; [@b44-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                                              15--140                                                                                 0.15--1.4                            4.5--42
  Philippines                                             [@b4-ehp-118-818]; [@b44-ehp-118-818]; [@b89-ehp-118-818][b](#tfn7-ehp-118-818){ref-type="table-fn"}                          44--54                                                                                  0.44--0.54                           13.2--16.2
  Republic of Korea                                       [@b79-ehp-118-818]; [@b83-ehp-118-818]                                                                                        1.2--6                                                                                  0.01--0.06                           0.36--1.80
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 15--50 (except Australia and New Zealand)                                               0.15--0.50                           4.5--15.0
                                                                                                                                                                                                                                                                                                                     
  Europe                                                                                                                                                                                                                                                                                                             
  Eastern Europe                                          [@b64-ehp-118-818][e](#tfn10-ehp-118-818){ref-type="table-fn"}                                                                3.5--4                                                                                  0.04                                 \~1.20
  Southern Europe                                         [@b14-ehp-118-818]; [@b31-ehp-118-818]^f^                                                                                     0--4                                                                                    0--0.04                              0--1.20
  Western Europe                                          [@b44-ehp-118-818]                                                                                                            0.3--1.3                                                                                0.003--0.01                          0.09--0.39
  In general[c](#tfn8-ehp-118-818){ref-type="table-fn"}                                                                                                                                 0--4                                                                                    0--0.04                              0--1.2

NHMRC, National Health and Medical Research Council.

Assuming 60 kg body weight per individual.

Aflatoxin exposure was estimated by multiplying aflatoxin concentrations in staple foods by consumption rates of those foods ([@b112-ehp-118-818]).

Aflatoxin exposure estimates and consequent HCC cases for all other countries classified in the same WHO region.

Aflatoxin exposure of 1--2 ng/kg body weight/day was measured in children's diets; here we assume the adult daily aflatoxin intake is 20% that of children.

Average daily aflatoxin intake was estimated based on AFB1 contamination levels in Czech maize, multiplied by average daily maize consumption in Eastern Europe. ^f^Average daily aflatoxin intake was estimated based on AFB1 contamination levels in maize of North Italy and Turkey, multiplied by average daily maize consumption in Southern Europe.

###### 

Estimated annual global burden of HCC cases attributable to aflatoxin exposure in HBsAg-positive and HBsAg-negative populations.

                                                                          Annual HCC cases   
  ------------------------------------------------------------- --------- ------------------ -----------------
  Africa                                                                                     
  Democratic Republic of Congo                                  68        1--173             1--551
  Ethiopia                                                      85        11--288            21--643
  The Gambia                                                    1.7       1--17              3--117
  Kenya                                                         38        11--450            44--2,270
  Mozambique                                                    21        73--361            111--1,200
  Nigeria                                                       149       1,800--2,940       8,200--13,400
  South Africa                                                  48        0--79              0--255
  Tanzania                                                      41        1--195             1--554
  Zimbabwe                                                      13        19--50             68--249
   Total region                                                 755       2,150--9,300       9,230--50,600
                                                                                             
  North America                                                                              
  Canada                                                        33        1                  1
  United States                                                 300       8                  1--5
   Total region                                                 333       9                  2--5
                                                                                             
  Latin America                                                                              
  Argentina                                                     40        0--16              0--5
  Brazil                                                        190       4--930             3--969
  Mexico                                                        109       152--924           14--83
   Total region                                                 562       589--2,980         84--2,060
                                                                                             
  Eastern Mediterranean                                                                      
  Egypt                                                         81        51--452            37--1400
  Iran                                                          66        33--56             4--9
  Pakistan                                                      172       116--832           119--851
  Sudan                                                         41        58--717            140--5,950
   Total region                                                 569       446--3,720         341--13,200
                                                                                             
  Southeast Asia                                                                             
  India                                                         1,150     438--11,200        331--16,200
  Indonesia                                                     237       203--2,820         160--4,340
  Thailand                                                      63        307--439           461--1,100
   Total region                                                 \~1,734   1,740--17,300      1,460--27,600
                                                                                             
  Western Pacific region                                                                     
  Australia                                                     21        0--1               0--1
  China                                                         1,300     1,990--4,430       5,300--14,400
  Korea                                                         50        5--29              6--45
  Malaysia                                                      28        40--372            63--588
  Philippines                                                   90        333--462           594--2,330
   Total region                                                 \~1,740   2,710--6,510       6,310--21,200
                                                                                             
  Europe                                                                                     
  Eastern Europe                                                290       94--114            61--244
  Southern Europe                                               144       0--56              0--121
  Western Europe                                                183       5--24              1--7
   Total region                                                 617       99--184            62--372
                                                                                             
  Total (world)                                                 6,280     7,700--40,000      17,500--115,000
   Total annual HCC cases attributable to aflatoxin worldwide             25,200--155,000    

Data from [@b19-ehp-118-818].
